Active control comparisons: the ideal trial designBrodie, M.J. and Whitehead, J. (2006) Active control comparisons: the ideal trial design. Epilepsy Research, 68 (1). 69-73 . ISSN 0920-1211 Full text not archived in this repository. It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing. To link to this item DOI: 10.1016/j.eplepsyres.2005.09.025 Abstract/SummaryThis report describes the concept for a clinical trial that uses carbamazepine as the gold-standard active control for a study of newly diagnosed patients. The authors describe an endpoint including efficacy and tolerability, and a stopping rule that uses a series of interim analyses in order to reach a conclusion as efficiently as possible without sacrificing reliability.
Altmetric Deposit Details University Staff: Request a correction | Centaur Editors: Update this record |
Lists
Lists
